In a filing, Opko Health Inc revealed its CEO & Chairman FROST PHILLIP MD ET AL acquired Company’s shares for reported $0.17 million on Apr 10 ’25. In the deal valued at $1.36 per share,125,000 shares were bought. As a result of this transaction, FROST PHILLIP MD ET AL now holds 214,001,448 shares worth roughly $265.36 million.
Then, FROST PHILLIP MD ET AL bought 125,000 shares, generating $184,650 in total proceeds. Upon buying the shares at $1.48, the CEO & Chairman now owns 213,876,448 shares.
Before that, FROST PHILLIP MD ET AL bought 100,000 shares. Opko Health Inc shares valued at $164,850 were divested by the CEO & Chairman at a price of $1.65 per share. As a result of the transaction, FROST PHILLIP MD ET AL now holds 213,751,448 shares, worth roughly $265.05 million.
JP Morgan initiated its Opko Health Inc [OPK] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including Barrington Research’s analysts, who increased its forecast for the stock in late June from “a Mkt perform” to “an Outperform”. H.C. Wainwright began covering OPK with “Buy” recommendation on December 15, 2022. Barrington Research revised its rating on January 24, 2022. It rated OPK as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of OPK
On Friday, Opko Health Inc [NASDAQ:OPK] saw its stock fall -1.59% to $1.24. Over the last five days, the stock has lost -10.47%. Opko Health Inc shares have fallen nearly -15.65% since the year began. Nevertheless, the stocks have fallen -4.62% over the past one year. While a 52-week high of $2.04 was reached on 03/05/25, a 52-week low of $1.19 was recorded on 05/09/25. SMA at 50 days reached $1.5884, while 200 days put it at $1.5485.
Levels Of Support And Resistance For OPK Stock
The 24-hour chart illustrates a support level at 1.2067, which if violated will result in even more drops to 1.1734. On the upside, there is a resistance level at 1.2766. A further resistance level may holdings at 1.3132. The Relative Strength Index (RSI) on the 14-day chart is 28.20, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1132, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.18%. Stochastics %K at 7.14% indicates the stock is a buying.
The most recent change occurred on June 21, 2021 when Ladenburg Thalmann began covering the stock and recommended ‘”a Buy”‘ rating along with a $7 price target.
